Inhibition of Hyaluronan Synthesis Reduces Versican and Fibronectin Levels in Trabecular Meshwork Cells

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Keller, Kate E ^a   Sun, Ying Ying ^a   Vranka, Janice A ^a   Hayashi, Lauren ^a   Acott, Ted S ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRILLIN 1; FIBRONECTIN; GLUCOSAMINE; GLUCOSE; HERMES ANTIGEN; HYALURONIC ACID; HYALURONIC ACID BINDING PROTEIN; HYALURONIDASE; HYMECROMONE; MESSENGER RNA; OSTEONECTIN; TENASCIN; VERSICAN;

ANIMAL CELL; ANIMAL TISSUE; AQUEOUS HUMOR OUTFLOW; ARTICLE; CARBOHYDRATE SYNTHESIS; CELL LEVEL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE; GENE SILENCING; HAS GENE; IMMUNOBLOTTING; INTRAOCULAR PRESSURE; NONHUMAN; POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRABECULAR MESHWORK; TRABECULAR MESHWORK CELL;

ANIMALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX PROTEINS; FIBRONECTINS; GENE EXPRESSION REGULATION; GENE SILENCING; GLUCOSAMINE; GLUCOSE; GLUCURONOSYLTRANSFERASE; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; HYMECROMONE; MICE; PROTEIN TRANSPORT; RNA, MESSENGER; SUBSTRATE SPECIFICITY; SUS SCROFA; TRABECULAR MESHWORK; URIDINE DIPHOSPHATE SUGARS; VERSICANS;

EID: 84868384643     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048523     Document Type: Article

References (58)

1. Polansky JR, Wood IS, Maglio MT, Alvarado JA, (1984) Trabecular meshwork cell culture in glaucoma research: evaluation of biological activity and structural properties of human trabecular cells in vitro. Ophthalmology 91: 580-595.
2. Gasiorowski JZ, Russell P, (2009) Biological properties of trabecular meshwork cells. Exp Eye Res 88: 671-675.
3. Johnson DH, Richardson TM, Epstein DL, (1989) Trabecular meshwork recovery after phagocytic challenge. Curr Eye Res 8: 1121-1130.
4. Johnson M, (2006) What controls aqueous humour outflow resistance?. Exp Eye Res 82: 545-557.
5. Acott TS, Kelley MJ, (2008) Extracellular matrix in the trabecular meshwork. Exp Eye Res 86: 543-561.
6. Fuchshofer R, Tamm ER, (2009) Modulation of extracellular matrix turnover in the trabecular meshwork. Exp Eye Res 88: 683-688.
7. Keller KE, Aga M, Bradley JM, Kelley MJ, Acott TS, (2009) Extracellular matrix turnover and outflow resistance. Exp Eye Res 88: 676-682.
8. Keller KE, Kelley MJ, Acott TS, (2007) Extracellular matrix gene alternative splicing by trabecular meshwork cells in response to mechanical stretching. Invest Ophthalmol Vis Sci 48: 1164-1172.
9. Boland MV, Quigley HA, (2007) Risk factors and open-angle glaucoma: classification and application. J Glaucoma 16: 406-418.
10. Barany EH, Scotchbrook S, (1954) Influence of testicular hyaluronidase on the resistance to flow through the angle of the anterior chamber. Acta Physiol Scand 30: 240-248.
11. Peterson WS, Jocson VL, (1974) Hyaluronidase effects on aqueous outflow resistance. Quantitative and localizing studies in the rhesus monkey eye. Am J Ophthalmol 77: 573-577.
12. Gum GG, Samuelson DA, Gelatt KN, (1992) Effect of hyaluronidase on aqueous outflow resistance in normotensive and glaucomatous eyes of dogs. Am J Vet Res 53: 767-770.
13. Knepper PA, Farbman AI, Telser AG, (1984) Exogenous hyaluronidases and degradation of hyaluronic acid in the rabbit eye. Invest Ophthalmol Vis Sci 25: 286-293.
14. Evanko SP, Tammi MI, Tammi RH, Wight TN, (2007) Hyaluronan-dependent pericellular matrix. Adv Drug Deliv Rev 59: 1351-1365.
15. Weigel PH, DeAngelis PL, (2007) Hyaluronan synthases: a decade-plus of novel glycosyltransferases. J Biol Chem 282: 36777-36781.
16. Toole BP, (2004) Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer 4: 528-539.
17. Viola M, Vigetti D, Genasetti A, Rizzi M, Karousou E, et al. (2008) Molecular control of the hyaluronan biosynthesis. Connect Tissue Res 49: 111-114.
18. Itano N, (2008) Simple primary structure, complex turnover regulation and multiple roles of hyaluronan. J Biochem 144: 131-137.
19. Itano N, Sawai T, Yoshida M, Lenas P, Yamada Y, et al. (1999) Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J Biol Chem 274: 25085-25092.
20. Acott TS, Westcott M, Passo MS, Van Buskirk EM, (1985) Trabecular meshwork glycosaminoglycans in human and cynomolgus monkey eye. Invest Ophthalmol Vis Sci 26: 1320-1329.
21. Knepper PA, Goossens W, Palmberg PF, (1996) Glycosaminoglycan stratification of the juxtacanalicular tissue in normal and primary open-angle glaucoma. Invest Ophthalmol Vis Sci 37: 2414-2425.
22. Kultti A, Pasonen-Seppanen S, Jauhiainen M, Rilla KJ, Karna R, et al. (2009) 4-Methylumbelliferone inhibits hyaluronan synthesis by depletion of cellular UDP-glucuronic acid and downregulation of hyaluronan synthase 2 and 3. Exp Cell Res 315: 1914-1923.
23. Kakizaki I, Kojima K, Takagaki K, Endo M, Kannagi R, et al. (2004) A novel mechanism for the inhibition of hyaluronan biosynthesis by 4-methylumbelliferone. J Biol Chem 279: 33281-33289.
24. Nakamura T, Takagaki K, Shibata S, Tanaka K, Higuchi T, et al. (1995) Hyaluronic-acid-deficient extracellular matrix induced by addition of 4-methylumbelliferone to the medium of cultured human skin fibroblasts. Biochem Biophys Res Commun 208: 470-475.
25. Keller KE, Sun YY, Yang YF, Bradley JM, Acott TS, (2012) Perturbation of hyaluronan synthesis in the trabecular meshwork and the effects on outflow facility. Invest Ophthalmol Vis Sci 53: 4616-4625.
26. Wight TN, (2002) Versican: a versatile extracellular matrix proteoglycan in cell biology. Curr Opin Cell Biol 14: 617-623.
27. Zhao X, Russell P, (2005) Versican splice variants in human trabecular meshwork and ciliary muscle. Mol Vis 11: 603-608.
28. Keller KE, Bradley JM, Vranka JA, Acott TS, (2011) Segmental versican expression in the trabecular meshwork and involvement in outflow facility. Invest Ophthalmol Vis Sci 52: 5049-5057.
29. Keller KE, Bradley JM, Acott TS, (2009) Differential effects of ADAMTS-1,-4, and-5 in the trabecular meshwork. Invest Ophthalmol Vis Sci 50: 5769-5777.
30. Faralli JA, Schwinn MK, Gonzalez JM Jr, Filla MS, Peters DM, (2009) Functional properties of fibronectin in the trabecular meshwork. Exp Eye Res 88: 689-693.
31. Santas AJ, Bahler C, Peterson JA, Filla MS, Kaufman PL, et al. (2003) Effect of heparin II domain of fibronectin on aqueous outflow in cultured anterior segments of human eyes. Invest Ophthalmol Vis Sci 44: 4796-4804.
32. Gonzalez JM Jr, Hu Y, Gabelt BT, Kaufman PL, Peters DM, (2009) Identification of the active site in the heparin II domain of fibronectin that increases outflow facility in cultured monkey anterior segments. Invest Ophthalmol Vis Sci 50: 235-241.
33. McDonald JA, Camenisch TD, (2002) Hyaluronan: genetic insights into the complex biology of a simple polysaccharide. Glycoconj J 19: 331-339.
34. Mjaatvedt CH, Yamamura H, Capehart AA, Turner D, Markwald RR, (1998) The CSPG2 gene, disrupted in the hdf mutant, is required for right cardiac chamber and endocardial cushion formation. Dev Biol 202: 56-66.
35. Camenisch TD, Spicer AP, Brehm-Gibson T, Biesterfeldt J, Augustine ML, et al. (2000) Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. J Clin Invest 106: 349-360.
36. Vigetti D, Rizzi M, Viola M, Karousou E, Genasetti A, et al. (2009) The effects of 4-methylumbelliferone on hyaluronan synthesis, MMP2 activity, proliferation, and motility of human aortic smooth muscle cells. Glycobiology 19: 537-546.
37. Jokela TA, Jauhiainen M, Auriola S, Kauhanen M, Tiihonen R, et al. (2008) Mannose inhibits hyaluronan synthesis by down-regulation of the cellular pool of UDP-N-acetylhexosamines. J Biol Chem 283: 7666-7673.
38. Pelletier CC, Lambert JL, Borchert M, (2005) Determination of glucose in human aqueous humor using Raman spectroscopy and designed-solution calibration. Appl Spectrosc 59: 1024-1031.
39. Keller KE, Bradley JM, Kelley MJ, Acott TS, (2008) Effects of modifiers of glycosaminoglycan biosynthesis on outflow facility in perfusion culture. Invest Ophthalmol Vis Sci 49: 2495-2505.
40. Ponta H, Sherman L, Herrlich PA, (2003) CD44: from adhesion molecules to signaling regulators. Nat Rev Mol Cell Biol 4: 33-45.
41. Wu YJ, La Pierre DP, Wu J, Yee AJ, Yang BB, (2005) The interaction of versican with its binding partners. Cell Res 15: 483-494.
42. Day JM, Olin AI, Murdoch AD, Canfield A, Sasaki T, et al. (2004) Alternative splicing in the aggrecan G3 domain influences binding interactions with tenascin-C and other extracellular matrix proteins. J Biol Chem 279: 12511-12518.
43. Chiquet-Ehrismann R, Kalla P, Pearson CA, Beck K, Chiquet M, (1988) Tenascin interferes with fibronectin action. Cell 53: 383-390.
44. Acott TS, Keller KE, Kelley MJ (2010) Role of Proteoglycans in the Trabecular Meshwork. In: Dartt DA, Besharse JC, Dana R, editors. Encyclopedia of the Eye. San Diego: Elsevier. 170-178.
45. Rhee DJ, Haddadin RI, Kang MH, Oh DJ, (2009) Matricellular proteins in the trabecular meshwork. Exp Eye Res 88: 694-703.
46. Barker TH, Baneyx G, Cardo-Vila M, Workman GA, Weaver M, et al. (2005) SPARC regulates extracellular matrix organization through its modulation of integrin-linked kinase activity. J Biol Chem 280: 36483-36493.
47. Suwan K, Choocheep K, Hatano S, Kongtawelert P, Kimata K, et al. (2009) Versican/PG-M Assembles Hyaluronan into Extracellular Matrix and Inhibits CD44-mediated Signaling toward Premature Senescence in Embryonic Fibroblasts. J Biol Chem 284: 8596-8604.
48. Singh P, Carraher C, Schwarzbauer JE, (2010) Assembly of fibronectin extracellular matrix. Annu Rev Cell Dev Biol 26: 397-419.
49. Twarock S, Tammi MI, Savani RC, Fischer JW, (2010) Hyaluronan stabilizes focal adhesions, filopodia, and the proliferative phenotype in esophageal squamous carcinoma cells. J Biol Chem 285: 23276-23284.
50. Knepper PA, Goossens W, Hvizd M, Palmberg PF, (1996) Glycosaminoglycans of the human trabecular meshwork in primary open-angle glaucoma. Invest Ophthalmol Vis Sci 37: 1360-1367.
51. Vigetti D, Clerici M, Deleonibus S, Karousou E, Viola M, et al. (2011) Hyaluronan synthesis is inhibited by adenosine monophosphate-activated protein kinase through the regulation of HAS2 activity in human aortic smooth muscle cells. J Biol Chem 286: 7917-7924.
52. Golshani R, Lopez L, Estrella V, Kramer M, Iida N, et al. (2008) Hyaluronic acid synthase-1 expression regulates bladder cancer growth, invasion, and angiogenesis through CD44. Cancer Res 68: 483-491.
53. Funahashi M, Nakamura T, Kakizaki I, Mizunuma H, Endo M, (2009) Stimulation of small proteoglycan synthesis by the hyaluronan synthesis inhibitor 4-methylumbelliferone in human skin fibroblasts. Connect Tissue Res 50: 194-202.
54. Li Y, Li L, Brown TJ, Heldin P, (2007) Silencing of hyaluronan synthase 2 suppresses the malignant phenotype of invasive breast cancer cells. Int J Cancer 120: 2557-2567.
55. Mahaffey CL, Mummert ME, (2007) Hyaluronan synthesis is required for IL-2-mediated T cell proliferation. J Immunol 179: 8191-8199.
56. Stamer WD, Seftor RE, Williams SK, Samaha HA, Snyder RW, (1995) Isolation and culture of human trabecular meshwork cells by extracellular matrix digestion. Curr Eye Res 14: 611-617.
57. Polansky JR, Weinreb RN, Baxter JD, Alvarado J, (1979) Human trabecular cells. I. Establishment in tissue culture and growth characteristics. Invest Ophthalmol Vis Sci 18: 1043-1049.
58. Lu Z, Overby DR, Scott PA, Freddo TF, Gong H, (2008) The mechanism of increasing outflow facility by rho-kinase inhibition with Y-27632 in bovine eyes. Exp Eye Res 86: 271-281.